Ventolin and Lymphadenopathy mediastinal - a phase IV clinical study of FDA data

Summary:

Lymphadenopathy mediastinal is reported as a side effect among people who take Ventolin (albuterol), especially for people who are male, 50-59 old, also take Symbicort, and have High density lipoprotein decreased.

The phase IV clinical study analyzes which people have Lymphadenopathy mediastinal when taking Ventolin. It is created by eHealthMe based on reports of 50,731 people who have side effects when taking Ventolin from the FDA, and is updated regularly.

What is Ventolin?

Ventolin has active ingredients of albuterol. It is often used in asthma. eHealthMe is studying from 51,849 Ventolin users. Check the latest studies of Ventolin.

What is Lymphadenopathy mediastinal?

Lymphadenopathy mediastinal (an enlargement of the lymph nodes in the part of the chest that separates the lungs) is found to be associated with 519 drugs and 480 conditions by eHealthMe. Check the latest studies of Lymphadenopathy mediastinal.

On Jul, 14, 2026

50,731 people reported to have side effects when taking Ventolin.
Among them, 11 people (0.02%) have Lymphadenopathy mediastinal.

Could Ventolin cause Lymphadenopathy mediastinal?

Among these 11 people:

What is the gender of people who have Lymphadenopathy mediastinal when taking Ventolin? *

female: 36.36 %
male: 63.64 %

What is the age of people who have Lymphadenopathy mediastinal when taking Ventolin? *

What are other drugs people take besides Ventolin? *

What are other side effects people have besides Lymphadenopathy mediastinal? *

Cough: 10 people, 90.91%
Wheezing (a high-pitched whistling sound made while you breath): 9 people, 81.82%
Hilar Lymphadenopathy (disease of the lymph nodes due to infection): 9 people, 81.82%
Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection): 9 people, 81.82%
Dyspnea (difficult or laboured breathing): 9 people, 81.82%
Chest Pain: 9 people, 81.82%
Pleural Effusion (water on the lungs): 9 people, 81.82%
Upper Respiratory Tract Infection: 9 people, 81.82%
Productive Cough: 8 people, 72.73%
Sleep Apnea Syndrome: 8 people, 72.73%

What are the existing conditions these people have? *

Prostate Cancer: 1 person, 9.09%
Osteoporosis (bones weak and more likely to break): 1 person, 9.09%
Lung Neoplasm Malignant (cancer tumour of lung): 1 person, 9.09%
High Density Lipoprotein Decreased: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Ventolin and have Lymphadenopathy mediastinal?

- Check whether Lymphadenopathy mediastinal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ventolin:

Ventolin (51,849 reports)

Browse all side effects of Ventolin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Lymphadenopathy mediastinal:

Lymphadenopathy mediastinal (519 drugs)

Browse all the conditions that are associated with Lymphadenopathy mediastinal:

Lymphadenopathy mediastinal (480 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on albuterol (the active ingredients of Ventolin) and Ventolin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.